歡迎來到北京鍵凱科技股份有限公司官方網站!

京ICP備05043698號  北京鍵凱科技股份有限公司

>
>
Azide PEG Amine, TFA Salt
瀏覽量:
產品名稱:

Azide PEG Amine, TFA Salt

產品代號:
AZIDE-PEG5000-NH2TFA
產品純度:
≥ 95%
分子量:
3500 Da, 5000 Da等
產品編號:
A5239
沒有此類產品
產品描述

  鍵凱科技提供高品質疊氮化物PEG胺,產品取代率≥95%。

  鍵凱科技生產的異雙功能疊氮化物PEG胺產品通常用作兩種不同化學物質的交聯劑或間隔物。此異功能PEG衍生物中的PEG部分可提供水溶性、生物相容性及柔性。此產品專門應用于抗體偶聯藥物(ADC’s)的開發。

  鍵凱科技提供AZIDE-PEG-NH2TFA分子量3500 Da, 5000 Da的產品1克和5克包裝。

  鍵凱科技提供分裝服務,需要收取分裝費用,如果您需要分裝為其他規格請與我們聯系。

  鍵凱科技同時提供其他分子量的AZIDE-PEG-NH2TFA衍生物產品,如你需要請與我司[email protected]聯系。

  鍵凱科技提供大批量生產產品及GMP級別產品,如需報價請與我們聯系。

References:

1. Coppock, M.B., et al., A novel discovery, maturation, and assay integration approach for the development of ruggedized multi-valent capture receptors exemplified against the chikungunya virus E2 protein, Sensing and Bio-Sensing Research, 2019, V. 22.

2. Sun, T., et al., A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion, Biomaterials, 2018.

3. Yu, S., et al., A density gradient of VAPG peptides on a cell-resisting surface achieves selective adhesion and directional migration of smooth muscle cells over fibroblasts. Acta biomaterialia, 2018, 72, pp.70-81.

4. Ma, H., et al., Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer, Journal of pharmaceutical sciences, 2018, 107(2), pp.595-603.

5. Ma, H., DHA and pGPMA Dual Modified pH Sensitive Polymeric Micelles for Target Treatment of Liver Cancer, Journal of Pharmaceutical Sciences, 2017.

6. Pei, X., et al., Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel. Scientific Reports, 2017, 7(1):975.

7. Ackerman, D.S., et al., Tethered fluorogen assay to visualize membrane apposition in living cells, Bioconjugate Chemistry, 2017.

8. Zhou, X., et al., d‐Fructose Modification Enhanced Internalization of Mixed Micelles in Breast Cancer Cells via GLUT5 Transporters, Macromolecular Bioscience, 2017.

9. Guo, Y., et al., Cell Microenvironment-Controlled Antitumor Drug Releasing-Nanomicelles for GLUT1-Targeting Hepatocellular Carcinoma Therapy, ACS Applied Materials and Interfaces, 2015.

未找到相應參數組,請于后臺屬性模板中添加
暫未實現,敬請期待
暫未實現,敬請期待
上一篇
下一篇
二手海王捕鱼主机